Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Smith & Nephew plc (SNN) vs TE Connectivity plc Ordinary Shares (TEL) Price & Performance

Smith & Nephew plcTrade
TE Connectivity plc Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Smith & Nephew plc vs TE Connectivity plc Ordinary Shares — how do they compare? Smith & Nephew plc trades at $26.9 (market cap $11.31B), while TE Connectivity plc Ordinary Shares trades at $214.01 (market cap $62.49B). The key difference: TE Connectivity plc Ordinary Shares is far larger — about 5.5× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

SNNTEL
Market Cap
$11.31B$62.49B
Volume
1,050,0051,845,947
Sector
HealthTechnology
52-Week High
$37.17$249.00
52-Week Low
$26.42$195.84
Typical Hold Time
120 Days—
Enterprise Value
$14.35B$66.88B
Dividend Yield
2.95%1.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Smith & Nephew plc

SNN trades at $26.96, near its 52-week low, with a bearish technical signal. The company has shown improving fundamentals, with revenue growing from $5.2B in 2022 to $6.16B in 2025 and net income margin expanding to 10.08%. Recent product launches, like the EVOS PELVIC System, highlight innovation, but the stock faces negative sentiment from analyst downgrades and CFO departure news.

The outlook is mixed: strong profitability and cash flow support value, but bearish technicals and cautious analyst consensus (26% buy, 65% hold) suggest limited near-term upside. Key risks include execution challenges and competitive pressures. Investors should weigh solid fundamentals against weak market sentiment.

TE Connectivity plc Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →

About TE Connectivity plc Ordinary Shares

TE Connectivity designs and manufactures connectivity and sensor solutions. Its products support transportation, energy networks, industrial automation, communications infrastructure, and medical technology.

Read more on TEL →